Skip to main content

United States News All stories

Every story in this section, newest first — page 316 of 373.

Grafa
Health

Dr. Reddy’s beats revenue forecasts despite US generic headwinds

Dr. Reddy’s Laboratories (NYSE:RDY) reported fiscal third-quarter revenue that surpassed analyst expectations Wednesday, as explosive growth in emerging markets and a resilient domestic business in India helped offset a steep decline in its North American generic portfolio.

Read more: Dr. Reddy’s beats revenue forecasts despite US generic headwinds